Research ExplorerJournalsEUR J CANCER Publications

EUR J CANCER - European journal of cancer (Oxford, England : 1990)

101 - 144 out of 144Page size: 50

Publications

  1. 2011

  2. Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - results of a matched-pair analysis.

    Rades, D., Schroeder, U., Bajrovic, A. & Schild, S. E., 2011, In: EUR J CANCER. 47, 18, p. 2729-2734 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2010

  4. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types

    Hummel, R., Hussey, D. J. & Haier, J., 01.2010, In: EUR J CANCER. 46, 2, p. 298-311 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients.

    Arraras, J. I., Greimel, E., Sezer, O., Chie, W-C., Bergenmar, M., Costantini, A., Young, T., Vlasic, K. K. & Velikova, G., 2010, In: EUR J CANCER. 46, 15, p. 2726-2738 15.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Head to head comparison of three generations of Partin tables to predict final pathological stage in clinically localised prostate cancer.

    Augustin, H., Isbarn, H., Auprich, M., Bonstingl, D., Al-Ali, B. M., Mannweiler, S. & Pummer, K., 2010, In: EUR J CANCER. 46, 12, p. 2235-2241 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies.

    Müller, V., Alix-Panabières, C. & Pantel, K., 2010, In: EUR J CANCER. 46, 7, p. 1189-1197 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells.

    Schröder, C., Schumacher, U., Müller, V., Wirtz, R. M., Streichert, T., Richter, U., Wicklein, D. & Milde-Langosch, K., 2010, In: EUR J CANCER. 46, 9, p. 1650-1660 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. 2009

  10. Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91

    von Hoff, K., Hinkes, B., Gerber, N. U., Deinlein, F., Mittler, U., Urban, C., Benesch, M., Warmuth-Metz, M., Soerensen, N., Zwiener, I., Goette, H., Schlegel, P. G., Pietsch, T., Kortmann, R. D., Kuehl, J. & Rutkowski, S., 05.2009, In: EUR J CANCER. 45, 7, p. 1209-17 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.

    Stang, A., Fischbach, R., Teichmann, W., Bokemeyer, C. & Braumann, D., 2009, In: EUR J CANCER. 45, 10, p. 1748-1756 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. [F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study.

    Steuber, T., Schlomm, T., Heinzer, H., Zacharias, M., Ahyai, S., Chun, F., Haese, A., Klutmann, S., Köllermann, J., Sauter, G., Mester, J., Mikecz, P., Fisch, M., Huland, H., Graefen, M. & Salomon, G., 2009, In: EUR J CANCER.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis.

    Rody, A., Karn, T., Ruckhäberle, E., Hanker, L., Metzler, D., Müller, V., Solbach, C., Ahr, A., Gätje, R., Holtrich, U. & Kaufmann, M., 2009, In: EUR J CANCER. 45, 3, p. 405-413 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.

    Lughezzani, G., Jeldres, C., Isbarn, H., Sun, M., Shariat, S. F., Alasker, A., Pharand, D., Widmer, H., Arjane, P., Graefen, M., Montorsi, F., Perrotte, P. & Karakiewicz, P. I., 2009, In: EUR J CANCER.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Prognostic impact of thymidine phosphorylase expression in breast cancer - Comparison of microarray and immunohistochemical data.

    Ruckhäberle, E., Karn, T., Engels, K., Turley, H., Hanker, L., Müller, V., Schmidt, M., Ahr, A., Gaetje, R., Holtrich, U., Kaufmann, M. & Rody, A., 2009, In: EUR J CANCER.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: A North American validation.

    Lughezzani, G., Sun, M., Perrotte, P., Jeldres, C., Alasker, A., Isbarn, H., Budäus, L., Shariat, S. F., Guazzoni, G., Montorsi, F. & Karakiewicz, P. I., 2009, In: EUR J CANCER.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study.

    Ludwig, H., Aapro, M., Bokemeyer, C., Macdonald, K., Soubeyran, P., Turner, M., Albrecht, T. & Abraham, I., 2009, In: EUR J CANCER. 45, 9, p. 1603-1615 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. 2008

  19. Cerebral metastases in non-seminomatous germ cell tumour patients undergoing primary high-dose chemotherapy.

    Oechsle, K., Kollmannsberger, C., Honecker, F., Boehlke, I. & Bokemeyer, C., 2008, In: EUR J CANCER. 44, 12, p. 1663-1669 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.

    Sammler, C., Beyer, J., Bokemeyer, C., Hartmann, J. T. & Rick, O., 2008, In: EUR J CANCER. 44, 2, p. 237-243 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.

    Borgmann, A., Zinn, C., Hartmann, R., Herold, R., Kaatsch, P., Escherich, G., Möricke, A., Henze, G. & von Stackelberg, A., 2008, In: EUR J CANCER. 44, 2, p. 257-268 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. 2007

  23. Antisense treatment of IGF-IR induces apoptosis and enhances chemosensitivity in central nervous system atypical teratoid/rhabdoid tumours cells.

    D'cunja, J., Shalaby, T., Rivera, P., von Bueren, A., Patti, R., Heppner, F. L., Arcaro, A., Rorke-Adams, L. B., Phillips, P. C. & Grotzer, M. A., 2007, In: EUR J CANCER. 43, 10, p. 1581-1589 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

    Chun, F., Briganti, A., Graefen, M., Erbersdobler, A., Walz, J., Schlomm, T., Meschke, M., Haese, A., Valiquette, L., Huland, H. & Karakiewicz, P. I., 2007, In: EUR J CANCER. 43, 2, p. 375-382 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.

    Hutterer, G., Perrotte, P., Gallina, A., Walz, J., Jeldres, C., Traumann, M., Suardi, N., Saad, F., Bénard, F., Valiquette, L., McCormack, M., Graefen, M., Montorsi, F. & Karakiewicz, P. I., 2007, In: EUR J CANCER. 43, 7, p. 1180-1187 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.

    Maier, S., Nimmrich, I., Koenig, T., Eppenberger-Castori, S., Bohlmann, I., Paradiso, A., Spyratos, F., Thomssen, C., Müller, V., Nährig, J., Schittulli, F., Kates, R., Lesche, R., Schwope, I., Kluth, A., Marx, A., Martens, J. W. M., Foekens, J. A., Schmitt, M. & Harbeck, N., 2007, In: EUR J CANCER. 43, 11, p. 1679-1686 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Enhancement of docetaxel efficacy in head and neck cancer treatment by G0 cell stimulation.

    Hambek, M., Werner, C., Baghi, M., Gstöttner, W. & Knecht, R., 2007, In: EUR J CANCER. 43, 10, p. 1502-1507 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.

    Bokemeyer, C., Aapro, M. S., Courdi, A., Foubert, J., Link, H., Osterborg, A., Repetto, L. & Soubeyran, P., 2007, In: EUR J CANCER. 43, 2, p. 258-270 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Interferon-gamma mediated up-regulation of caspase-8 sensitizes medulloblastoma cells to radio- and chemotherapy.

    Meister, N., Shalaby, T., von Bueren, A., Rivera, P., Patti, R., Oehler, C., Pruschy, M. & Grotzer, M. A., 2007, In: EUR J CANCER. 43, 12, p. 1833-1841 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Prostate volume and adverse prostate cancer features: fact not artifact.

    Briganti, A., Chun, F., Suardi, N., Gallina, A., Walz, J., Graefen, M., Shariat, S., Ebersdobler, A., Rigatti, P., Perrotte, P., Saad, F., Montorsi, F., Huland, H. & Karakiewicz, P. I., 2007, In: EUR J CANCER. 43, 18, p. 2669-2677 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.

    Chun, F., Briganti, A., Jeldres, C., Gallina, A., Erbersdobler, A., Schlomm, T., Walz, J., Eichelberg, C., Salomon, G., Haese, A., Eichelberg, E., Ahyai, S., Bénard, F., Huland, H., Graefen, M. & Karakiewicz, P. I., 2007, In: EUR J CANCER. 43, 3, p. 536-543 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. 2005

  33. The Fos family of transcription factors and their role in tumourigenesis

    Milde-Langosch, K., 11.2005, In: EUR J CANCER. 41, 16, p. 2449-61 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Alphavbeta5-integrins mediate early steps of metastasis formation

    Enns, A., Korb, T., Schlüter, K., Gassmann, P., Spiegel, H-U., Senninger, N., Mitjans, F. & Haier, J., 05.2005, In: EUR J CANCER. 41, 7, p. 1065-72 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Long-term observation reveals time-course-dependent characteristics of tumour vascularisation.

    Hansen-Algenstaedt, N., Joscheck, C., Schäfer, C., Lamszus, K., Wolfram, L., Biermann, T., Algenstaedt, P., Brockmann, M. A., Heintz, C., Fiedler, W. & Rüther, W., 2005, In: EUR J CANCER. 41, 7, p. 1073-1085 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma.

    Friedrich, M., Chandrasoma, S., Siegmund, K. D., Weisenberger, D. J., Cheng, J. C., Toma, M. I., Huland, H., Jones, P. A. & Liang, G., 2005, In: EUR J CANCER. 41, 17, p. 2769-2778 17.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Surgical management of prostate cancer: advances based on a rational approach to the data.

    Meraney, A. M., Haese, A., Palisaar, J., Graefen, M., Steuber, T., Huland, H. & Klein, E. A., 2005, In: EUR J CANCER. 41, 6, p. 888-907 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. 2004

  39. The future of clinical cancer research: who's teaching the next generation? The Flims-Vail model.

    Palmieri, C., Wanaski, S., Panse, J. & Medeiros, B., 2004, In: EUR J CANCER. 40, 2, p. 173-175 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. 2002

  41. Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma.

    Dahl, A., Schachner, M., Moll, I., Berger, J., Schulze, H-J., Brunner, G. & Schumacher, U., 2002, In: EUR J CANCER. 38, 13, p. 1708-1716 13.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. 2001

  43. Disseminated choriocarcinoma in infancy is curable by chemotherapy and delayed tumour resection

    Blohm, M. E., Calaminus, G., Gnekow, A. K., Heidemann, P. H., Bolkenius, M., Weinel, P., von Schweinitz, D., Ambros, P. F., Schneider, D. T., Harms, D. & Göbel, U., 01.2001, In: EUR J CANCER. 37, 1, p. 72-8 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  44. 1998

  45. 10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE).

    Erttmann, R., Tafese, T., Berthold, F., Kerbl, R., Mann, J., Parker, L., Schilling, F., Ambros, P., Christiansen, H., Favrot, M., Kabisch, H., Hero, B. & Philip, T., 1998, In: EUR J CANCER. 34, 9, p. 1391-1397 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. 1997

  47. Rhabdomyolysis and renal function impairment after isolated limb perfusion--comparison between the effects of perfusion with rhTNF alpha and a 'triple-drug' regimen

    Hohenberger, P., Haier, J. & Schlag, P. M., 04.1997, In: EUR J CANCER. 33, 4, p. 596-601 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.

    von Schweinitz, D., Byrd, D. J., Hecker, H., Weinel, P., Bode, U., Bürger, D., Erttmann, R., Harms, D. & Mildenberger, H., 1997, In: EUR J CANCER. 33, 8, p. 1243-1249 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Expression of a 260 kDa neuroblastoma surface antigen, the target of cytotoxic natural human IgM: correlation to MYCN amplification and effects of retinoic acid.

    David, K., Ehrhardt, A., Ollert, M. W., Erttmann, R., Bredehorst, R. & Vogel, C. W., 1997, In: EUR J CANCER. 33, 12, p. 1937-1941 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Mechanisms of in vivo anti-neuroblastoma activity of human natural IgM.

    Ollert, M. W., David, K., Vollmert, C., Juhl, H., Erttmann, R., Bredehorst, R. & Vogel, C. W., 1997, In: EUR J CANCER. 33, 12, p. 1942-1948 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. 1996

  52. Demonstration of p53 protein and TP53 gene mutations in oligodendrogliomas

    Hagel, C., Laking, G., Laas, R., Scheil, S., Jung, R., Milde-Langosch, K. & Stavrou, D. K., 12.1996, In: EUR J CANCER. 32A, 13, p. 2242-2248 7 p., 13.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?

    Bielack, S. S., Erttmann, R., Kempf-Bielack, B. & Winkler, K., 1996, In: EUR J CANCER. 32, 10, p. 1652-1660 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. 1991

  55. Conserved cytostatic activity of aclarubicin in a doxorubicin selected Friend leukaemia cell line with multifactorial multidrug resistance.

    Erttmann, R., Münchmeyer, M., Looft, G. & Winkler, K., 1991, In: EUR J CANCER. 27, 8, p. 1064 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. 1981

  57. Depopulation and repopulation of the R1H rhabdomyosarcoma of the rat after X-irradiation.

    Jung, H., Beck-Bornholdt, H-P., Brammer, I. & Zywietz, F., 1981, In: EUR J CANCER. 17, 4, p. 375-386 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  58. 1977

  59. Childhood malignant lymphoma. Favourable outlook with aggressive combination chemotherapy and radiotherapy.

    Lau, B. M., Janka-Schaub, G., Meister, P., Lampert, F. & Haas, R. J., 1977, In: EUR J CANCER. 13, 11, p. 1237-1240 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 Next